Global Specialty Pharmaceutical Company

A global specialty Pharmaceutical company that develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical products selected The Powers Company to help them improve efficiencies. The pharmaceutical company offers specialty dosage and sterile injectable drug products and is advancing an R&D pipeline of potential new products.

Click here to download a PDF copy of this article

Save it to read later, or share with a colleague

Problems

  • Excessive batch errors
  • QC lab 20% retest rate
  • Applications that cannot interface
  • No facility coordination of batch record speed

Objectives

The time required to move products from bulk completion to product release had grown to a sluggish average of 40 days with a $3.1 million back order. The Powers Company was engaged to improve release cycle time and release efficiencies.

Strategy

The POWERS Company implemented robust QC Lab reporting tools to monitor efficiency, test quality and test cycle times. A supply Chain Operating report was implemented to tie together production, QC Lab and QA performance metrics.

Created a batch record cycle time database, improving visibility and transparency of the approval and sign-off process.

Results

67%

Reduced days in lab test sample time

46%

Reduced product release time

36%

Reduced overall lab test cycle time

85%

Reduced time to begin testing samples